May 2011. The Native Antigen Company (NAC); http://thenativeantigencompany.com announces the release of highly purified Clostridium difficile toxins A & B and toxoids A & B for use by in-vitro diagnostic (IVD) manufacturers and researchers as immunogens, positive controls or for determining clinical assay range...
To satisfy a broad range of IVD applications and in particular the increasing diagnostic trend to test for both pathogenic strains of C.difficle, the toxins and toxoids are offered as separate preparations. Each is is available either frozen or lyophilised and in a choice of vial sizes..
For more information please contact Andrew Maxwell, CEO Native Antigen Company +44 (0) 01869 238067, amaxwell@thenativeantigencompany.com
or visit www.thenativeantigencompany.com
